Clinical Trials
29 trialsNCT04749394 2022-08-16
A Study of Camrelizumab Plus Apatinib as Consolidation Therapy in Non-Small Cell Lung Cancer Patients Treated With Chemoradiotherapy
ChineseAMS
Phase 2 Unknown
NCT04762459 2022-02-24
APEX
ChineseAMS
Phase 3 Enrolling by invitation
NCT04500145 2021-02-01
Simultaneous Integrated Boost vs. Routine IMRT in Limited-stage Small-cell Lung Cancer
ChineseAMS
Phase 3 Unknown
NCT04683198 2020-12-24
Camrelizumab Combined With Apatinib ,Carboplatin and Etoposide in Participants With ES-SCLC
ChineseAMS
Phase 2 Unknown
NCT04620837 2020-11-09
Tislelizumab in Combination With Anlotinib With ES-SCLC as Maintenance Therapy After First Line Chemotherapy
ChineseAMS
Phase 2 Unknown
NCT00880971 2020-10-05
Postoperative Radiotherapy for Patients With IIIA (N2) Non-small Cell Lung Cancer
ChineseAMS
Phase 3 Completed
NCT04535739 2020-09-02
PCI for Patients With ES-SCLC After RCT:a Prospective Randomized Study
ChineseAMS
Phase 3 Unknown
NCT02346955 2020-08-27
MK-6018-001
KitovPharma
Phase 1 Terminated
NCT02014805 2020-07-16
Postoperative Conformal Radiotherapy for Stage II-III B Type Thymoma
ChineseAMS
Phase 3 Unknown
NCT04056923 2019-08-14
3D Printing for Nodule Localization
GuangdongPPH
Phase NA Completed
NCT03971214 2019-06-04
PICARES
ChineseAMS
Phase 1 Unknown
NCT03916913 2019-04-17
TKI Followed by Thoracic Radiotherapy for Stage IV EGFR Mutant NSCLC
ChineseAMS
Phase NA Unknown
NCT02675088 2019-04-04
Comparable Study of Different Thoracic Radiotherapy Regimens for Extensive Stage Small Cell Lung Cancer
ChineseAMS
Phase NA Unknown
NCT02688036 2018-01-02
Hypofractionated vs. Conventionally Fractionated Concurrent CRT for LD-SCLC
ChineseAMS
Phase 3 Unknown
NCT02995187 2017-09-07
Study of Apatinib as Third-line and Later Therapy in Patients With Small Cell Lung Cancer (SCLC)
ChineseAMS
Phase 2 Unknown
NCT02960607 2016-11-18
High-dose Icotinib Treatment Beyond Progression in EGFR Mutant NSCLC
ChineseAMS
Phase 2 Unknown
NCT02961270 2016-11-11
Icotinib in Non-small Cell Lung Cancer Patients With Uncommon EGFR Mutation
ChineseAMS
Phase 2 Unknown
NCT02771756 2016-05-13
The Effect of Zhen Qi Shen Capsule Combined With Yu Yi Kang on Breast Cancer and Lung Cancer Patients With Chemotherapy
ChineseAMS
Phase NA Unknown
NCT02584699 2015-10-23
Study of Stereotactic Ablative Radiotherapy (SABR) in Elderly Stage I NSCLC
ChineseAMS
Phase 2 Unknown
NCT01955824 2014-12-30
A Trial on Clinical Efficacy of 1% Versus 2% Lignocaine in Cough Suppression and Pain Relief in Patients Undergoing Flexible Bronchoscopy
PIMERIndia
Phase 2/3 Completed
NCT02323737 2014-12-30
Phase II Study of Irinotecan and Cisplatin in Extensive-stage Small Cell Lung Cancer
ChineseAMS
Phase 2 Completed
NCT00600587 2013-06-25
Induction Erlotinib Therapy in Stage III A (N2) Non-Small Cell Lung Cancer (NSCLC)
GuangdongPPH
Phase 2 Completed
NCT01850147 2013-05-09
Sequential Use of Low-dose Sunitinib With Chemotherapy in Advanced NSCLC After Failure of Conventional Regimen
ChineseAMS
Phase 2 Unknown
NCT01503385 2012-01-04
Cisplatin/Etoposide and Concurrent Radiotherapy With or Without Celecoxib in Patients With Unresectable Locally Advanced Non-small Cell Lung Cancer (NSCLC)
ChineseAMS
Phase 2 Unknown
NCT01494558 2011-12-19
Study of Etoposide, Cisplatin, and Radiotherapy Versus Paclitaxel, Carboplatin and Radiotherapy to Treat Non-Small Cell Lung Cancer
ChineseAMS
Phase 2/3 Completed
NCT00963716 2009-08-21
Hot and Cold Biopsy Forceps in the Diagnosis of Endobronchial Lesions
PIMERIndia
Phase NA Completed
NCT00663689 2008-04-22
Efficacy of Erlotinib for Brain Metastasis of Non-Small Cell Lung Cancer
GuangdongPPH
Phase 2 Unknown
NCT00614809 2008-02-22
Efficacy of Gefitinib for Brain Metastasis of Non-Small Cell Lung Cancer
GuangdongPPH
Phase 2 Unknown
NCT00430664 2007-02-02
A Comparative Study of the Safety and Efficacy of Face Talc Slurry and Iodopovidone for Pleurodesis
PIMERIndia
Phase NA Unknown